The Neuropeptide CGRP Induces Bipolar Syndrome in Group 2 Innate Lymphoid Cells
- PMID: 31618650
- DOI: 10.1016/j.immuni.2019.09.015
The Neuropeptide CGRP Induces Bipolar Syndrome in Group 2 Innate Lymphoid Cells
Abstract
In this issue of Immunity, Nagashima et al., Wallrapp et al., and Xu et al. demonstrate that the neuropeptide calcitonin gene-related peptide (CGRP) fine tunes type 2 innate immune response via suppressing group 2 innate lymphoid cells (ILC2s).
Copyright © 2019 Elsevier Inc. All rights reserved.
Comment on
-
Neuropeptide CGRP Limits Group 2 Innate Lymphoid Cell Responses and Constrains Type 2 Inflammation.Immunity. 2019 Oct 15;51(4):682-695.e6. doi: 10.1016/j.immuni.2019.06.009. Epub 2019 Jul 25. Immunity. 2019. PMID: 31353223 Free PMC article.
-
Calcitonin Gene-Related Peptide Negatively Regulates Alarmin-Driven Type 2 Innate Lymphoid Cell Responses.Immunity. 2019 Oct 15;51(4):709-723.e6. doi: 10.1016/j.immuni.2019.09.005. Epub 2019 Oct 8. Immunity. 2019. PMID: 31604686 Free PMC article.
-
Transcriptional Atlas of Intestinal Immune Cells Reveals that Neuropeptide α-CGRP Modulates Group 2 Innate Lymphoid Cell Responses.Immunity. 2019 Oct 15;51(4):696-708.e9. doi: 10.1016/j.immuni.2019.09.004. Immunity. 2019. PMID: 31618654 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials